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Abstract In microorganisms, the enzyme acetate kinase
(AK) catalyses the formation of ATP from ADP by de-
phosphorylation of acetyl phosphate into acetic acid. A
mutant strain of Clostridium acetobutylicum lacking acetate
kinase activity is expected to have reduced acetate and
acetone production compared to the wild type. In this work,
a C. acetobutylicummutant strain with a selectively disrupted
ack gene, encoding AK, was constructed and genetically and
physiologically characterized. The ack− strain showed a re-
duction in acetate kinase activity of more than 97% compared
to the wild type. The fermentation profiles of the ack− and
wild-type strain were compared using two different fermenta-
tion media, CGM and CM1. The latter contains acetate and
has a higher iron and magnesium content than CGM. In
general, fermentations by the mutant strain showed a clear
shift in the timing of peak acetate production relative to
butyrate and had increased acid uptake after the onset of
solvent formation. Specifically, in acetate containing CM1
medium, acetate production was reduced by more than 80%
compared to the wild type under the same conditions, but both
strains produced similar final amounts of solvents. Fermenta-
tions in CGM showed similar peak acetate and butyrate levels,
but increased acetoin (60%), ethanol (63%) and butanol (16%)
production and reduced lactate (−50%) formation by the
mutant compared to the wild type. These findings are in
agreement with the proposed regulatory function of butyryl
phosphate as opposed to acetyl phosphate in the metabolic
switch of solventogenic clostridia.
Keywords Acetone butanol ethanol fermentation . ABE
fermentation . Acetate kinase . Acid production .Clostridium
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Introduction
The expected shortage of petroleum in the near future and
concerns regarding the net increase of carbon dioxide emis-
sions by fossil fuel combustion have resulted in a search for
sustainable sources for the production of transport fuels and
chemicals. Butanol derived from lignocellulosic materials
could provide such an alternative method to the current
petrochemical production process (Dürre 2008; Lee et al.
2008). Fermentative butanol production is carried out by
various clostridial species as part of the acetone–butanol–
ethanol (ABE) process (Green 2011; Jones and Woods
1986; Lee et al. 2008; Lütke-Eversloh and Bahl 2011).
Two of the most important drawbacks of the ABE process
are the low butanol yields, due to the formation of by-
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products and the toxicity of butanol itself to the cultures, and
the high costs of the separation of the different products
(Jones 2001).
Several strategies to increase the production of butanol
and reduce by-product formation by metabolic engineering
have been described (López-Contreras et al. 2010; Rogers et
al. 2006). To date, only two gene knockouts (phosphotran-
sacetylase, pta; butyrate kinase, buk1) (Green et al. 1996;
Shao et al. 2007) and five asRNA constructs (acetoacetyl-
CoA:acetate/butyrate:CoA-transferase, ctfA and ctfB; ace-
toacetate decarboxylase, adc; phosphotransbutyrylase, ptb;
buk1) (Desai and Papoutsakis 1999; Tummala et al. 2003a, b)
pertaining directly to the reduction of by-product formation in
C. acetobutylicumATCC 824 have been reported. Inactivation
of buk1 resulted in a 42% increase in butanol levels
(Harris et al. 2000) while inactivation of the pta, involved in
acetate formation, did not show improved solvent production
(WTA-B-E production, 72:133:13 mM vs. 79:131:11 for the
pta− mutant) (Green et al. 1996).
In related strains, three genes have been knocked out: adc
in C. acetobutylicum EA 2018 (Jiang et al. 2009) and acetate
kinase (ack) and buk1, both in C. acetobutylicum M5
(Sillers et al. 2008). Impairment of the acetone pathway
results in all cases in increased acid accumulation, as
expected for strains that can no longer efficiently take-up
acids from the growth medium. Strain M5 is a degenerated
strain, isolated after chemical mutagenesis, which no longer
has the pSOL1 megaplasmid and therefore is devoid of
solvent production (Clark et al. 1989). To restore solvent
productivity, Nair and Papoutsakis (1994) expressed the
alcohol dehydrogenase gene (adhE), normally located on
pSOL1, in strain M5 from a replicative plasmid. Butanol
and ethanol production was restored without acetone forma-
tion, but at reduced levels compared to the wild-type ATCC
824 strain, while large amounts of acetate and butyrate
accumulated in the growth medium. To reduce the acid
production in this M5 background, Sillers et al. (2008)
created an acetate kinase knockout strain (M5 AKKO) and
a butyrate kinase knockout strain (M5 BKKO). Both strains
had reduced, but not eliminated, acid accumulation
corresponding to the inactivated pathway and grew more
slowly. Attempts to restore solvent formation by these acid
production mutants by plasmid based adhE expression were
unsuccessful for the M5 BKKO strain. M5 AKKO could be
transformed, but it still produced large amounts of acetate
and butyrate with reduced alcohol production compared to
the M5 adhE expressing strain.
Based on the fermentation results of the pta− and buk−
mutants and a later study measuring the intracellular levels
of phosphorylated acids inC. acetobutylicum, it was proposed
that butyryl phosphate is a regulatorymolecule involved in the
transition from acidogenesis into solventogenesis (Zhao et al.
2005). The enzymes involved in acetate production in C.
acetobutylicum, phosphotransacetylase and acetate kinase,
are encoded by the pta-ack operon. AC. acetobutylicum strain
in which the acetate kinase (ack) gene is inactivated is
expected to accumulate acetyl phosphate, a phosphory-
lated intermediate with a potential regulatory function in
Escherichia coli (Klein et al. 2007; McCleary et al.
1993). On the contrary, a pta− mutant is not expected to
accumulate this intermediate (McCleary et al. 1993). The
influence of ack disruption on solvent production in a wild-
type background has not been studied yet.
Formation of acetate, butyrate, ethanol and acetone limits
the amount of metabolic precursors available for butanol
production. In our current research, we therefore focus on
reducing formation of these by-products by a targeted gene
disruption. By inactivating the genes involved in their pro-
duction, we wished to investigate the effects on the overall
metabolism and butanol production.
In this study, we describe a mutant of C. acetobuty-
licum with an inactivated acetate kinase (ack) gene,
obtained using the ClosTron system for selective gene
inactivation in Clostridia (Heap et al. 2007). The resulting
ack− mutant has been characterized, and its fermentation
profile under batch conditions has been compared to that of
the wild-type strain.
Materials and methods
Bacterial strains and plasmids
All bacterial strains and plasmids used in this study are listed
in Table 1. Stock cultures of C. acetobutylicum were main-
tained as spore suspensions in sterile 15% (v/v) glycerol at
−20 °C. Chemical competent E. coli TOP 10 cells (Invitrogen)
were used for vector maintenance and cloning.
Media and growth conditions
E. coli strains were grown in lysogeny broth (LB) me-
dium (Bertani 2004; Sambrook et al. 1989) at 37 °C,
200 rpm supplemented with the appropriate antibiotics.
Clostridial spore suspensions were prepared as previously
described (Siemerink et al. 2011) and heat-shocked for
10 min at 70 °C, prior to using them as an inoculum for pre-
cultures. Liquid cultures of C. acetobutylicum were grown in
CM1 medium, based on Nimcevic et al. (1998), containing per
litre: yeast extract, 5.00 g; KH2PO4, 1.00 g, K2HPO4, 0.76 g;
ammonium acetate, 3.00 g; para-aminobenzoic acid (pABA),
0.10 g; MgSO4•7 H2O, 1.00 g; FeSO4•7 H2O, 0.50 g and
glucose, 100 g or in CGM (Roos et al. 1985) containing per
litre: yeast extract, 5.00 g; KH2PO4, 0.75 g; K2HPO4, 0.75 g;
asparagine•H2O, 2.27 g; (NH4)2SO4, 2.00 g; cysteine, 0.50 g;
MgSO4•7 H2O, 0.40 g; MnSO4•H2O, 0.01 g; FeSO4•7 H2O,
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0.01 g and glucose, 80 g. Media were made anaerobic by
flushing with nitrogen gas for 10 to 30 min depending on the
volume of the liquid. All clostridial culture experiments were
performed at 37 °C, without shaking, and anaerobically in
(a) an anaerobic chamber (Sheldon Manufacturing, Oregon
USA; gas mixture consisting of 15% CO2, 4% H2 and 81%
N2) or (b) in glass serum vials as described previously
(López-Contreras et al. 2000).
Culture media were supplemented with ampicillin
(100 μg mL-1), chloramphenicol (30 μg mL-1), thiampheni-
col (15 μg mL-1), erythromycin (40 μg mL-1 standard; 5–
10 μg mL-1 for initial mutant isolation) or kanamycin
(50 μg mL-1) when appropriate. Biomass was determined
spectrophotometrically (Pharmacia Biotech Ultrospec 2000)
based on a experimentally determined relationship between
optical density measurements (OD600) and cell dry weight
[CDW 0 (OD600–0.40)/2.91].
DNA isolation, manipulation and transformation
Standard molecular work was done according to established
protocols (Sambrook et al. 1989). DNA from C. acetobuty-
licum was isolated using the GenElute Bacterial Genomic
DNA Kit (Sigma-Aldrich) using the Gram-positive isolation
procedure which incorporates a lysozyme (from chicken egg
white; Fluka) treatment. E. coli plasmid DNA was isolated
by the GenElute Plasmid Miniprep Kit (Sigma-Aldrich).
Both kits were used according to the manufacturers’ instruc-
tions. DNA amplification by PCR on C. acetobutylicum
DNAwas done using Pwo polymerase (Roche Diagnostics),
and E. coli colony PCR reactions were carried out using
REDTaq DNA polymerase (Sigma-Aldrich).
Prior to transformation into C. acetobutylicum, plasmids
were methylated in vivo (Mermelstein and Papoutsakis
1993) by electroporation into E. coli TOP 10 (pAN2) cells.
Electrotransformation of C. acetobutylicum was carried out
as previously described (Oultram et al. 1988). All manipu-
lations were carried out anaerobically and on ice. After
transformation and recovery, the cells were plated on pre-
warmed plates containing thiamphenicol.
Primers and DNA sequencing
All DNA primers used in the study are listed in Table 2.
Primers were obtained from Eurogentec (Seraing, Belgium).
DNA sequencing of clones was done by BaseClear (Leiden,
the Netherlands).
Construction of ClosTron plasmids
Plasmids were constructed according to the protocol by
Heap et al. (2007) using the Sigma Targetron design website
(www.sigma-genosys.com/targetron/). The retargeted cas-
settes were ligated into the pMTL007 backbone, resulting
in plasmids pMTL007::Cac-ack-1027a and pMTL007::
Cac-ack-84 s. Correct plasmids were identified by restriction
digestion and by sequencing the retargeted region using
primers 5402F_fwd and pMTL007_rev.
Table 1 Strains and plasmids
Strains Relevant characteristics Remarks Source
E. coli TOP10 Cloning strain Invitrogen
E. coli TOP10 (pAN2) Methylation strain This study
C. acetobutylicum WUR Originally obtained as ATCC 824 but shown to
deviate from type strain behaviour
(Siemerink et al. 2011)
Laboratory stock
C. acetobutylicum WUR AK ack−, ermB Acetate kinase knockout mutant of WUR strain This study
Plasmids
pAN2 p15A ori; TcR Φ3t I Met Methylation plasmid derived from pAN1 but
with tetracycline resistance selection
Laboratory stock
(Heap et al. 2007)
pMTL007::Cac-spo0A-242a ColE1 ori, pCB102 ori; CamR
LtrA intron II
Supplied pMTL007 backbone and is a positive
control targeted to insert in spo0A between
bp 242 and 243 in the antisense orientation
Laboratory stock
(Heap et al. 2007)
pMTL007::Cac-ack-1027a ColE1 ori, pCB102 ori; CamR
LtrA intron II
Targeted to insert in ack between bp 1027 and
1028 in the antisense orientation
This study
pMTL007::Cac-ack-84s ColE1 ori, pCB102 ori; CamR
LtrA intron II
Targeted to insert in ack between bp 84 and 85
in the sense orientation
This study
ermB confers resistance to erythromycin, p15A ori E. coli origin of replication, TcR tetracycline resistance, Φ3t I Met Bacillus subtilis phage Φ3t I
methyltransferase gene, ColE1 ori E. coli origin of replication, pCB102 ori clostridial origin of replication, CamR chloramphenicol resistance, LtrA
the intron-encoded protein of the Lactococcus lactis Ll.LtrB group II intron
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Induction of the ClosTron system and mutant
isolation and verification
One-millilitre CGM with thiamphenicol was inoculated with
a 100-μL stationary phase overnight culture and incubated
for 1.5 h at 37 °C. Then IPTG was added to a final concen-
tration of 1 mM, and incubation was continued for 3 h. Cells
were centrifuged at 5,200×g for 1 min, and the supernatant
was removed. After addition of 0.5 mL PBS, cells were
resuspended and centrifuged again at 5,200×g for 2 min.
The supernatant was removed and replaced with 1-mL
CGM without antibiotics. The cells were resuspended and
incubated for 3 h at 37 °C before plating on CGM agar
plates containing 5 μg mL−1 erythromycin and incubated for
1 or 2 days at 37 °C. Selected colonies were restreaked on
plates containing 10 μg mL−1 erythromycin. Isolated
mutants were checked for absence of the 1.3-kb plasmid sized,
intron I containing, ermB gene using primers ErmRAM-F and
ErmRAM-R.
Southern blot
Genomic DNA of the wild type, the AK mutant and the
pMTL007 plasmid was restriction digested using four dif-
ferent mixes for each sample (KpnI and SacI, BglII and
EcoRV, HindIII, HpaII). Digests were then subjected to
Southern blot analysis using a random-labelled DIG probe
(Roche) and was performed according to the manufacturer’s
instructions. Primers TT_Probe_f and TT_Probe_r were
used to generate the probe, with pMTL007 plasmid DNA
as a template. The resulting probe hybridised to nucleotides
312 to 694 of the inserted intron II sequence. Irrespective of
restriction enzyme used, no DNA fragment was released
from the wild-type genomic DNA that hybridised to the
probe. In contrast, restriction fragments of the expected size
were derived from both the genome of the AK mutant and
the ClosTron plasmid which gave a positive signal on the
Southern blot.
Cell-free extracts and enzymatic activity assays
C. acetobutylicum cells were harvested from cultures with
an OD of approximately 1.0 by centrifugation (15,000×g,
7 min, 4 °C) and resuspended in 50 mMMOPS buffer (pH0
7.0) containing 1 mM DTT. Crude cell extracts were pre-
pared by French press (Thermo Scientific) homogenization
(two passes at 16,000 psi). The homogenates were centri-
fuged (20,817×g, 15 min, 4 °C) decantated and centrifuged
as before. The cell-free extracts were stored at −80 °C until
analysed. AK and BK were assayed at 29 °C in the acyl
phosphate forming direction according to the method of
Rose (1955). Units of AK or BK activity were defined as
micromoles of substrate converted per minute. Acetyl phos-
phate was used for preparation of a calibration curve for
both reactions. Phosphotransacetylase (PTA) and phospho-
transbutyrylase (PTB) activities were measured in the acyl
phosphate forming direction by measuring the release of
coenzyme A as previously described (Cary et al. 1988).
Units of PTA or PTB activity were defined as micro-
moles of CoA released per minute. Homogenisation and
enzyme assays were carried out aerobically. Total pro-
tein in crude extracts was determined using Quick Start
Bradford Protein Assay (Bio-Rad) with bovine serum
albumin as a standard.
Table 2 Primer sequences
aNucleotides that are not
complementary to the template
sequence are given in uppercase.
HindIII and BsrGI restriction
sites incorporated in the
primers are underlined
Primer name Sequence (5′→ 3′)a
AK1027a_ibs aaaaaagctt ataattatcc ttaTGTTTcT GCATAgtgcg cccagatagg gtg
AK1027a_ebs1d cagattgtac aaatgtggtg ataacagata agtcTGCATATTtaacttac ctttctttgt
AK1027a_ebs2 tgaacgcaag tttctaattt cgGttAAACA Tcgatagagg aaagtgtct
AK84s_ibs aaaaaagctt ataattatcc ttaGTACTcG CTAAAgtgcg cccagatagg gtg
AK84s_ebs1d cagattgtac aaatgtggtg ataacagata agtcGCTAAA GGtaacttac ctttctttgt
AK84s_ebs2 tgaacgcaag tttctaattt cgAttAGTAC Tcgatagagg aaagtgtct
EBS_Univ cgaaattaga aacttgcgtt cagtaaac
Cac_ack_fwd atgaaaaact tagttattaa ctgcg
Cac_ack_rev ttattttaac ttgcctacta tatcttt
5402F_fwd ttaaggaggt gtatttcata tgaccatgat tacg
pMTL007_rev agggtatccc cagttagtgt taagtcttgg
ErmRAM-F acgcgttata ttgataaaaa taataatagt ggg
ErmRAM-R acgcgtgcga ctcatagaat tatttcctcc cg
TT_Probe_f aatctgtagg agaacctatg ggaacg
TT_Probe_r cgcgtcgcca cgtaataaat atctgg
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Batch fermentations of C. acetobutylicum
Fermentations were performed in 2 L bioreactors (1 L
working volume) controlled via a Bio Controller ADI
1010 by a PC running Bioexpert software (all Applikon,
the Netherlands). No antibiotics were used during the
fermentations. CGM batch fermentations were set up as
follows: Yeast extract, phosphates, ammonium sulphate
and asparagine were autoclaved with the reactor, whereas
autoclaved glucose was added to the reactor after cooling.
Metal sulphates and cysteine were added filter-sterilised.
CM1 medium-based batch fermentations were setup by
autoclaving yeast extract, phosphates and ammonium
acetate with the reactor. Autoclaved glucose was added to
the reactor after cooling. Metal sulphates and pABA were
added as a filter sterilised mix.
The medium in the reactor was sparged overnight with
nitrogen. Prior to inoculation, Sigma antifoam 204 was
added to the reactor (0.1‰). The reactor was inoculated
with 50 mL of an overnight pre-culture grown on the same
medium but supplemented with erythromycin in the case of
the mutant. After inoculation, the starting pH was allowed to
fall to 5.0, after which it was controlled by addition of 6 M
ammonium hydroxide solution (CGM) or 4 M KOH (CM1).
During the fermentation, the headspace was flushed with
nitrogen and the outgoing gas flow was passed through a
condenser at 4 °C. The agitation rate was 200 rpm.
Analysis of metabolites
Metabolites present in culture supernatants (glucose, acetate,
butyrate, lactate, acetoin, meso-2,3-butanediol, acetone, buta-
nol and ethanol) were determined by HPLC as described
previously (Siemerink et al. 2011) using valeric acid as an
internal standard.
Results
ack gene disruption
Sequencing of the acetate kinase gene (ack or askA,
CA_C1743) of the C. acetobutylicum WUR strain showed
that it is identical to the published genomic sequence of the
ATCC 824 strain (data not shown). After submitting the
gene sequence to the TargeTron website, ten possible insertion
sites were returned. The two top scoring ones were selected
for our mutagenesis work. Each site requires its own set of
three unique primers and a general one (EBS_Univ) for the
splicing by overlap extension (SOEing) PCR (Heap et al.
2007; Ho et al. 1989) that is used to replace the standard
sequence with a sequence that will recognise the desired
insertion site. The first set of unique primers, consisting of
AK1027a_ibs, AK1027a_ebs1d and AK1027a_ebs2, was
used to target the intron to insert in the anti-sense orientation
between base pairs 1027 and 1028 of ack. The second set of
unique primers, consisting of AK84s_ibs, AK84s_ebs1d and
AK84s_ebs2, targeted the intron to insert in the sense orien-
tation between base pairs 84 and 85 (Table 2).
The retargeted plasmids were constructed as described in
the materials and methods section. Transformation of the
plasmids, selection and induction of the intron II system
resulted in erythromycin-resistant colonies. Colonies were
screened for insertion in the ack gene by PCR on genomic
DNA using primers Cac_ack_fwd and Cac_ack_rev. Of the
eight colonies screened, three were positive for insertion
between base pairs 1027 and 1028. Of the 16 screened
colonies that contained the pMTL007::Cac-ack-84 s
construct, none showed insertion in the ack gene. All
of the screened colonies tested positive by PCR for a
correctly sized ermB gene of approximately 900 bps
(the length of the active, genomically inserted, ermB gene).
This shows that in the cases where the ack gene was not
affected, the intron II must have integrated somewhere else
in the genome.
The insertion efficiency at the intended site of the
pMTL007::Cac-ack-84 s system appeared to be lower than
that for the pMTL007::Cac-ack-1027a system, and there-
fore, no further attempts were made to isolate a mutant with
insertion at the 84/85 site. One of the successful 1027a
insertants was selected and further purified by re-streaking
on fresh erythromycin plates. DNA isolated from this mutant
strain was analysed by PCR amplification of the full-length
ack gene using primers Cac_ack_fwd and Cac_ack_rev. Only
a 3.0-kbp PCR product was obtained, corresponding to the
ack gene with an inserted intron. The absence of a wild type,
1.2 kbp amplicon, indicated that a pure culture was obtained
(Fig. S1). Loss of the pMTL007 plasmid by the mutant was
confirmed by PCR using the ermB gene primers (not shown).
To check if only one copy of the intron had inserted in the
genome, a Southern blot was performed. The probe employed
was complementary to nucleotides 312 to 694 of the inserted
intron sequence. Only bands, corresponding to the expected
sizes, were detected (Fig. S2). Also this analysis confirmed
that pMTL007 plasmid DNA was not present in the sample.
Insertion of the intron II at the intended site in the ack
gene was confirmed by sequencing (data not shown).
Spore suspensions from the obtained mutant, designated
C. acetobutylicum AK, were used for further studies.
Activities of acetate and butyrate pathway enzymes
The characterisation of the mutant was performed using two
different media. CGM medium, which has been used previ-
ously for the characterisation of similar mutants (Green et al.
1996) and does not contain acetate, was selected in order to
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be able to compare our results to earlier reports and to
observe acid production without background levels, while
CM1 medium is used routinely in our laboratory for growth
experiments and contains 39 mM acetate and a higher
concentration of iron and magnesium than CGM.
To confirm functional inactivation of acetate kinase, cell-
free extracts of exponentially growing cultures were assayed
for enzyme activities involved in acid production. The de-
termined specific enzyme activities are shown in Table 3.
Acetate kinase enzyme activity in cells from cultures grown
in both media was reduced by more than 97% compared to
the wild type. The PTA activity, encoded by the pta gene
which resides upstream of ack in the same operon, was also
negatively affected by the insertion, being reduced by 41%
in CM1 medium and 29% in CGM. Interestingly, BK activ-
ity, involved in butyrate production and encoded by the ptb–
buk1 operon, also showed reduced activity in both media.
While PTB activity was still comparable (90% and 100%
activity of the wild type in CM1 and CGM medium, respec-
tively), BK activity was reduced to 72% and 53% activity of
the wild type in, respectively, CM1 and CGM medium.
Characterisation of the C. acetobutylicum AK mutant
in batch cultures on CM1 medium
Product formation by the mutant strain was studied using
pH-controlled batch cultures. The initial pH of the cultures
was 6.6, and it was allowed to drop to 5.0 before it was
controlled by addition of potassium hydroxide. Final product
concentrations of duplicate fermentations after approximately
47 h are presented in Table 4. Figure 1 shows a typical
fermentation profile in this medium. During fermentations
by the wild-type strain on CM1 medium, both acetate and
butyrate accumulated in the broth during the acidogenic phase
of the fermentations. Butyrate production reached an average
maximum of 62 mM, whereas the maximum average acetate
concentration was 85 mM, a 43-mM increase relative to the
starting concentration of 42 mM (Table 4). Both acids were, to
some extent, taken up during the solventogenic phase of the
fermentation. Butyrate levels dropped to around 16 mM, but
acetate levels remained 27 mM above the starting concentra-
tion (Fig. 1a). Solvent production by the wild type reached
concentrations of 161, 101 and 30 mM for butanol, acetone
and ethanol, respectively. The C. acetobutylicum AK strain
consumed somewhat less glucose but had increased acetate
assimilation. Final concentrations of solvents of C. acetobu-
tylicum AK strain fermentations (157, 98 and 35 mM for
butanol, acetone and ethanol, respectively) were similar to
those in wild-type fermentations. The production of acids by
the AK mutant was markedly different. Acetate levels
increased with only 9 mM, a reduction of 79% compared to
the wild-type strain. The maximum butyrate levels were also
lower compared to the wild-type fermentations (47 vs.
62 mM; Fig. 1c). During the solventogenic phase of
fermentations by the AK strain, butyrate was re-assimilated
to reach similar levels as in fermentations by the wild-type
strain. Contrary to butyrate, the acetate re-assimilation by the
AK mutant resulted in net consumption (7 mM) of initially
present acetate.
Characterisation of the AK mutant in batch cultures
on CGM medium
To allow more precise monitoring of acetate levels, we
characterised the mutant in CGM medium, which contrary
to CM1 does not contain any acetate. In addition, CGM
medium has been used in earlier fermentation studies with
C. acetobutylicum (Green et al. 1996). Figure 2 shows
typical optical density and production profiles of acids and
solvents from wild-type and AK strain fermentations. The
average product levels for three independent fermentations
per strain after a minimum of 72 h are shown in Table 4.
Fermentations by the AK mutant strain consistently reached
a higher biomass concentration than the wild type. Typical
Table 3 Specific enzyme activities involved in production of acetate and butyrate in wild-type and AK mutant homogenates
Growth mediuma Strain Specific activities (U mg−1)b
Acetate pathway Butyrate pathway
PTA AK PTB BK
CM1 WT 0.40±0.05 3.1±0.4 9.18±0.02 1.4±0.1
AK 0.24±0.01 (59%) 0.08±0.02 (2.7%) 8.3±0.5 (90%) 1.0±0.3 (72%)
CGM WT 0.30±0.03 3.4±0.1 7.4±1.3 1.2±0.1
AK 0.212±0.007 (71%) 0.064±0.004 (1.9%) 7.5±0.1 (100%) 0.66±0.05 (53%)
a Cells were harvested when OD60001.0
b Data are reported as the mean ± SEM (n02). In the case of homogenates from the AK
mutant, the relative activity compared to that of the wild type is given in parentheses.
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values of dry weight biomass concentration obtained were
4.5±0.3 mg mL−1 for the wild-type and 5.5±0.1 mg mL−1
for the AK mutant (Table 4). An interesting observation was
that the fermentation broths from the AK mutant strain
showed an intense yellow colour at the end of every fer-
mentation, which was not the case for wild-type cultures.
Spectrofotometrical analysis of the broth supernatant gave a
local absorption maximum at 450 nm, suggesting increased
build-up of riboflavin (vitamin B2) in the medium.
During the fermentation, acetate was still produced by the
AK strain but at slightly reduced maximum levels (WT
30 mM, AK 26 mM) compared to the wild type, as is shown
in Fig. 2a, c. Maximum butyrate levels also did not seem to
be affected to a great extent, with somewhat higher values
for the mutant (WT 38 mM, AK 43 mM). There was,
however, a clear difference at what time point, compared
to one another, the maximum acetate and butyrate levels
were reached. The production of acetate by the AK mutant
was delayed compared to that of butyrate. This difference
was best observed by plotting the ratio between butyrate and
acetate at various time points (Fig. 3a). From the start of the
fermentation by the wild type, the ratio between butyrate
and acetate rose, levelling off after 9 h at 1.5 and
stayed at that ratio for 7 h. The ratio in fermentations
by the AK strain continued to increase with a maximum
of 4.3 after 14 h. The ratio then decreased to similar
levels as those observed for the wild type, and both
reached a minimum of 0.1. Analysis of the fermentations with
CM1 medium gave a similar difference in acid ratio
production (Fig. 3b).
Lactate, normally only detected at low levels (Green et al.
1996; Jones and Woods 1986), if at all, in C. acetobutylicum
ATCC 824 fermentations in CGM medium, was produced in
all three fermentations by C. acetobutylicum WUR (57±
7 mM). The AK mutant also produced lactate but consis-
tently at lower levels (28±2 mM). Various attempts—filter
sterilisation of minerals, reduced stirring speed, extended
sparging time with nitrogen gas before inoculation—were
Table 4 End-point product concentrations and fermentation parameters of 1 L batch fermentations (pH 5.0) using CM1 and CGM as cultivation
media by the C. acetobutylicum WT strain and the AK mutant strain
CM1 CGM
Wild typed AKd Changee (%) Wild typef AKf Changee (%)
Fermentations 2 2 3 3
Consumed glucose (mM) 372 (± 5) 353 (± 6) 358 (± 7) 345 (± 11)
Final acetate (mM) 69 (± 7) 34 (± 4) 30 (± 5) 29 (± 4)
Relative acetatea (mM) 27 (± 7) −7 (± 4) −128 n.a. n.a.
Butyrate (mM) 16 (± 0.4) 13 (± 1) 29 (± 3) 4.3 (± 2) −85
Lactate (mM) 2 (± 0.2) 3 (± 0.7) 57 (± 7) 28 (± 2) −51
Butanolb (mM) 161 (± 2) 157 (± 7) 131 (± 1) 152 (± 2) +16
Acetoneb (mM) 101 (± 3) 98 (± 7) 40 (± 6) 36 (± 5)
Ethanolb (mM) 30 (± 1) 35 (± 4) 24 (± 2) 39 (± 2) +59
Acetoinc (mM) 11 (± 1) 19 (± 5) 15 (± 0.7) 24 (± 1) +58
Biomass (mg mL−1) 4.57 (± 0.01) 6.5 (± 0.4) 4.5 (± 0.3)g 5.5 (± 0.1)g +22
Carbon recovery (including biomass) 93% 98% 83% 86%
(Butanol + ethanol)/acetone (mol/mol) 1.9 2.0 4.0 5.5
Solvent yield based on
mol butanol/mol glucose 0.43 0.45 0.37 0.44
g ABE/g glucose 0.29 0.30 0.20 0.24 +20
a Relative acetate is calculated by the subtracting the initial acetate level at time of inoculation from the measured acetate levels later during the
fermentation
b Due to evaporation, ethanol and acetone levels dropped at the end of the fermentation. Peak recorded values were used
c Both the wild-type and the AK mutant strain also produced low levels (2–4 mM) of meso-2,3-butanediol as previously described
(Siemerink et al. 2011)
d Data as mean (± SEM) based on two independent experiments
e If significant (t test, >95% confidence), then the relative change in product levels is given
f Data as mean (± SEM) based on three independent experiments
g Data based on two independent experiments
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made to reduce lactate production in fermentations by the
wild-type, but without success.
Butanol and ethanol production by the AK mutant were,
respectively, 16% and 59% higher compared to the wild-
type production. Acetone production levels were not signif-
icantly affected. The conversion of glucose to butanol by the
mutant had increased with 19%, and total solvent yields
from glucose were up with 21% (0.54 mol ABE/mol
glucose consumed vs. 0.66mol ABE/mol glucose consumed).
The final concentration of the by-product acetoin had
increased with 58%, from 15mMwith the wild type to 24mM
for the mutant.
Discussion
The inactivation of the butyrate kinase (buk1) gene of C.
acetobutylicum has previously been shown to result in re-
duced butyrate formation, increased peak acetate levels and
increased butanol and ethanol production (Harris et al.
2000). Acetone is one of the major by-products of butanol
production as it is formed as a consequence of the uptake of
acids from the medium. It has been shown through a com-
putational approach that even under solvent forming con-
ditions acetate production continues, while extracellular
acetate levels drop (Desai et al. 1999). Produced acetate is
Fig. 1 Typical optical density and production profile of a wild-type (a
and b) and AK mutant strain (c and d) fermentation in pH 5.0 con-
trolled batch reactors using CM1 medium containing 100 gL−1
glucose. a, c Production of acids acetate, butyrate, lactate,
solid line pH, , OD600. b, d production of solvents ethanol,
butanol, acetone, acetoin, OD600
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continuously converted to acetyl-CoA, mediated by the
enzyme acetoacetyl-CoA:acetate/butyrate:CoA transferase,
ultimately resulting in acetone production. This approach
allows C. acetobutylicum to continue acetate-mediated ATP
generation during the solventogenic phase. With the aim to
reduce the formation of acetate and indirectly that of ace-
tone, by C. acetobutylicum, we have inactivated the acetate
kinase (ack) gene which encodes the enzyme catalysing the
last step in acetate production. In this substrate level phos-
phorylation reaction, the phosphate group of acetyl phos-
phate is transferred to ADP, generating ATP and acetate. In
addition, we were interested to see if solvent formation
would be similarly beneficially affected, as reported for
buk1 gene disruption (Harris et al. 2000).
In this study, site-directed gene disruption was accom-
plished by integration of a group II intron using the ClosTron
system (Heap et al. 2007). This system is markedly different
from the non-replicative plasmid integration-based approach
used for the previously generated buk1 and pta mutants of C.
acetobutylicum (Green et al. 1996). Mutations based on single
cross-over recombination are inherently unstable, whereas
insertion of the group II intron in the anti-sense orientation,
relative to the gene, results in permanent inactivation (Heap et
al. 2007). The ClosTron and a similarly adapted TargeTron
Fig. 2 Typical optical density and production profile of a wild-type (a
and b) and AK mutant strain (c and d) fermentation in pH 5.0 con-
trolled batch reactors using CGM containing 80 gL−1 glucose. a, c
Production of acids acetate, butyrate, lactate, solid line pH,
OD600. b, d Production of solvents ethanol, butanol,
acetone, acetoin, OD600
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system (Shao et al. 2007) have been used to generate various
mutants, including adc and hbd knockout mutants (Jiang et al.
2009; Lehmann and Lütke-Eversloh 2011).
Successful insertion of the intron after transformation of
pMTL007::Cac-ack-1027a would, after translation of the
mutated gene, truncate the native sequence of the AK pro-
tein at amino acid 342. However, additional intron sequence
encoded amino acids will be added to the native sequence.
In the case of insertion after nucleotide 1027, the sequence
would be extended by 86 amino acids, so intron insertion
actually results in a protein that is 27 amino acids longer
than the native enzyme.
Although the retrohoming system of the group II introns
is expected to be site-specific, it is possible that no or only a
limited number of correctly positioned insertants can be
found (Heap et al. 2007; Perutka et al. 2004). Our results
show efficient insertion into insertion site 1027a, but for
insertion site 84 s, 16 screened colonies did not yield a correct
insertant. These results emphasise the need to test multiple
insertion sites when using TargeTron-based systems.
AK activity in the AK mutant was less than 3% of the
wild-type enzyme activity (Table 3), demonstrating that
while the insertion was close to the 3′ side of the ack gene,
it still resulted in functional inactivation of the enzyme. A
study by Singh-Wissmann et al. (1998) showed that a con-
served glutamate residue in sequence of the AK of Meth-
anosarcina thermophila near the C terminus is essential for
enzyme activity. This glutamate is conserved in acetate
kinase sequences from widely divergent organisms and is
also present in the C. acetobutylicum AK (Singh-Wissmann
et al. 1998). In our AK strain, this glutamate residue is not
present anymore, so no activity from the enzyme encoded
by the disrupted gene is expected, which is in line with the
low enzyme activities observed (Table 3).
It was expected that disruption of acetate kinase would
result in decreased acetate levels and increased butyrate
levels to compensate for the loss in ATP production (Lee
et al. 2009), but this was not immediately observed. In both
tested media, the AK mutant strain had peak butyrate levels
that were lower than those for the wild type, while peak
acetate levels were reduced compared to wild-type fermen-
tations. Final acetate levels were equal (CGM), or reduced
in comparison to wild-type fermentations.
The fact that inactivation of AK does not abolish acetate
production has been previously observed in both Clostridi-
um tyrobutyricum (Liu et al. 2006) and the degenerated C.
acetobutylicum strain M5 (Sillers et al. 2008). In the C.
tyrobutyricum ack− strain, the fermentation time was ex-
tended and both acetate and butyrate levels surpassed those
of the wild type. The M5 ack− strain (M5 AKKO) produced
acetate at reduced levels but with similar butyrate formation.
When a plasmid-based alcohol dehydrogenase (aad) is
expressed in M5 AKKO, acetate production is again high
(180 mM) while butyrate production levels are depended on
the fermentation pH ranging from 75 mM for pH 5.5 to
287 mM for pH 6.0 fermentations (Sillers et al. 2008). Lee
Fig. 3 Butyrate–acetate ratios in CGM (a) or butyrate-relative acetate
ratios CM1 (b) of a wild-type strain ( ) and AK mutant strain ( )
fermentation in pH 5.0 controlled batch reactors. On the horizontal
axis, normalized time is plotted to account for variations in lag time of
the cultures. In the graph, 9 h corresponds to an OD600 of 1.0. Relative
acetate is calculated by the subtracting the initial acetate level at time of
inoculation from the measured acetate levels later during the
fermentation
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et al. (2009) suggest that an alternative acetate-producing
pathway is operational in the M5 AKKO mutant. This could
also be applicable to our WUR strain and derived mutants.
Green et al. (1996) reported on another acetate pathway
mutant in C. acetobutylicum in which the pta gene was
inactivated. They reported reduced acetate levels and
increased butyrate levels compared to the WT under con-
ditions favouring acid formation (pH 5.5). Later data from
Zhao et al. (2005) from static flask batch cultures showed
that acetate levels were reduced by approximately 50%,
while butyrate levels were unaffected under these condi-
tions. Both culturing conditions are different from those
employed in this study and complicate a direct comparison.
While higher butyrate levels seem to correlate with increas-
ing pH, the reduction in acetate is common to both. This
would be in agreement with our lower butyrate levels at pH
5.0, but not with the acetate levels that we observed.
Apparently an AK negative mutant is more likely to
produce acetate than a mutant in which PTA is inactivated.
A similar observation can be made for C. tyrobutyricum pta−
and ack− mutants (Liu et al. 2006; Zhu et al. 2005) and is
likely due to the operon structure in both species in which ack
is located downstream of pta.
Besides an alternative acetate forming pathway, another
possible explanation for the continued acetate production by
the ack− mutants could be that acetate production is cata-
lysed by BK. BK from C. acetobutylicum is active on
acetate with 6% relative activity, in the acetyl phosphate-
forming direction, compared to butyrate, based on in vitro
data (Hartmanis 1987). Although BK activity is reduced in
CGM medium (Table 3), Desai and Papoutsakis (1999)
showed that even if BK activity is reduced by more the
80% in an asRNA mutant, butyrate fluxes remain unaffected
and butyrate accumulates in the growth medium. Apparently
the butyrate production pathway has a far greater catalytic
capacity, which could possibly be used for acetate formation.
CM1 and CGM media differ mainly in the respect that
the former contains more iron, magnesium and 39 mM
acetate (Table S1). The marked differences between fermen-
tation performances by the wild-type and C. acetobutylicum
AK strains grown on each medium are evident from the data
presented in Table 4. In CM1 medium acetate production is
strongly reduced (AK mutant 9 mM vs. WT 43 mM, both in
addition to the starting concentration of 42 mM), while in
CGM medium the peak acetate concentrations are quite
similar (AK 26 mM, WT 30 mM). The possible effect that
additional acetate in the medium has could be an indication
that the intracellular metabolism involved in acetate produc-
tion in the AK strain is sensitive to elevated levels of
extracellular acetate. Future experiments using CM1 medi-
um with varying, initial, concentrations of acetate can help
to determine if the same maximum acetate concentration of
50 mM is reached for both lower and higher starting
concentrations of acetate. This would support our current
observation that acetate production is inhibited at a lower
concentration (50 mM) in the AK strain than for the wild
type, which accumulates more than 80 mM of acetate in
CM1 medium under the same conditions. This is similar to
strain ATCC 824 that accumulates up to 71 mM in CGM
medium (Harris et al. 2000).
In both media, however, an important difference that was
observed between the mutant and the wild-type strain was
the delay in the acetate production. In the wild-type strain
fermentations, acetate and butyrate production occurs with
approximately 1.5 (CGM) or 1.8 times (CM1) as much
butyrate formed compared to acetate. Figure 3 clearly shows
that the AK mutant produces considerably more butyrate
[1.86 times (CGM) and 7.2 times (CM1)] than acetate in the
beginning of the fermentation, in line with the expectation
that acetate production would be negatively affected by an
AK disruption. It appears that when the butyrate concentration
has reached its maximum level, only then acetate production
is allowed to reach its full potential if no extracellular acetate
is present (CGMmedium). If indeed BK is involved in acetate
formation, then competition of acetyl phosphate and butyryl
phosphate for the available enzyme could explain the delayed
acetate production.
In CGM fermentations, lactate production was seen with
both the wild type and the mutant. Interestingly enough, the
AK mutant strain made considerably less lactate, but more
acetoin. The increase in acetoin (9 mM), however, is not
enough to account for the full reduction in lactate produc-
tion (29 mM), but only for up to 62%. Production of acetoin
does not require oxidation of a reducing equivalent (NADH)
(Freier and Gottschalk 1987) as is needed for lactate pro-
duction. This additional reduction capacity could have pos-
sibly been used for solvent formation instead. Lactate
production in CGM fermentations has been reported before
(approximately 70 mM) (Green et al. 1996) but only for
mutants, not for the WT. It seems that in our hands, C.
acetobutylicum WUR, contrary to the ATCC 824 strain, is
more likely to produce lactate under these fermentation
conditions in CGM, whereas it does not do so in CM1
medium. This is the second difference that we have
observed, next to meso-2,3-butanediol production (Siemerink
et al. 2011). A likely explanation for this behaviour could be
that the WUR strain is sensitive to lower levels of iron and/or
magnesium compared to the ATCC 824 strain. Both these
metal ions are co-factors in various oxidoreductase enzymes.
If the activity of these enzymes is compromised, then remod-
elling of the flow of reducing equivalents within the cell,
ultimately leading to lactate formation, could be the result.
Inactivation of the acetate pathway in the AK mutant is
expected to lead to accumulation of acetate-preceding intra-
cellular intermediates, such as acetyl CoA and acetyl phos-
phate. These higher intracellular levels could then alter
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product formation of ethanol and metabolically more up-
stream intermediates such as lactate and acetoin (Zhu and
Shimizu 2005). The increased acetoin and ethanol levels in
the AK mutant CGM fermentations follow the expected
trend (Table 4). The reduced lactate production levels of
the AK mutant, relative to those by the wild-type, are not in
line with this expectation. The wild-type C. acetobutylicum
WUR strain showed (high) lactate production levels on
CGM in contrast to strain ATCC 824 which produced none
under similar conditions (Desai and Papoutsakis 1999;
Harris et al. 2000). This dissimilarity could be due to a
different regulation of gene expression or different enzymatic
properties of the iso-enzymes involved in lactate forma-
tion in both strains.
Out rationale for disrupting AK activity was that it is
expected to result in intracellular accumulation of acetyl
phosphate. This accumulation could potentially be a molec-
ular trigger (McCleary et al. 1993) resulting in an observ-
able phenotype, akin to butyryl phosphate accumulation
after buk1 disruption (Harris et al. 2000). In CGM, there
was significant increase in acetoin, ethanol and butanol
formation by the AK mutant; however, the fermentations
of both the wild type and to a lesser extent the AK mutant
were affected by lactate production. In CM1 medium, hardly
any lactate was produced by both strains. The AK mutant
produced at peak levels 34 mM (79%) less acetate compared
to the wild-type strain, but no changes in the other fermenta-
tion products were seen. This supports the earlier observations
of Green et al. (1996) and Zhao et al. (2005) that acetate
pathway disruption in C. acetobutylicum does not result in
altered solvent production.
Despite the absence of an effect on acetone and butanol
formation in fermentations in CM1 medium, AK inactiva-
tion did result in increased acetate uptake in that medium
and increased butyrate uptake in CGM fermentations
(Table 4). Acetate production was only impaired when ace-
tate was present in the medium (CM1), but in both CGM
and CM1, an altered initial acetate/butyrate product ratio
was observed showing a reduced acetate production rate.
The absence of an impact on solvent production by the pta−
mutant of Green et al. (1996) and our AK mutant in CM1
medium is in agreement with the prediction by Zhao et al.
(2005) that levels of acetyl phosphate are not linked with
induction of solvent formation. Potential other roles of acetyl
phosphate cannot be excluded based on these experiments. It
is of further interest to note that the accumulation of a yellow
compound in the fermentation broth is likely to be riboflavin
(Demain 1972; Pridham 1952) which can help to facilitate the
economic competitiveness of the ABE fermentation process
(Cai and Bennett 2011).
We now propose the construction of an alcohologenic
strain, which is unable to produce either acetate or butyrate
and subsequently will not produce acetone because there are
no acids to be taken up from the medium. Ideally this strain
would produce only the alcohols butanol and ethanol when
grown on glucose. Construction of such a strain would
require the combined knockout of both acetate kinase
(ack) and butyrate kinase (buk1), so that it would no longer
be able to perform the, proposed, in vivo complementation
of acetate production by butyrate kinase. Such a mutant
would also allow us to test whether the remaining acetate
production in our AK mutant is due to complementation of
the enzyme activity by butyrate kinase or if one or more
alternative acetate-forming pathways operate in C. acetobu-
tylicum. We are currently investigating this option.
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